Peptides for targeting colorectal cancer, and medical use thereof
US10393744B2 · kind B2 · utility
0Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2015 |
| Grant date | Aug 27, 2019 |
| Priority date | — |
| Expiry date | Sep 30, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a peptide for targeting colorectal cancer, a composition for diagnosing radioresponsiveness-dependent prognosis of colorectal cancer using the peptide, and a drug delivery use of the peptide, wherein a functional peptide capable of targeting cancer has been discovered so as to implement personalized diagnosis and treatment for individual patients having cancer, in consideration of problems occurring during treatment in which treatment cases of respective patients differ due to different therapeutic responses resulting from genetic differences in the individual patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.